日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study

Magrolimab联合阿扎胞苷与医生选择方案治疗未经治疗的TP53突变型急性髓系白血病:ENHANCE-2研究

Zeidner, Joshua F; Sallman, David A; Récher, Christian; Daver, Naval G; Leung, Anskar Y H; Hiwase, Devendra K; Subklewe, Marion; Pabst, Thomas; Montesinos, Pau; Larson, Richard A; Wilde, Lindsay; Enjeti, Anoop K; Kawashima, Ichiro; Papayannidis, Cristina; O'Nions, Jenny; Johnson, Lisa; Dong, Mei; Huang, Julie; Bagheri, Taravat; Hacohen Kleiman, Gal; Lee, Calvin; Vyas, Paresh

Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.

MDS 对阿扎胞苷的临床反应与 HSPC 中独特的 DNA 甲基化变化有关

Thoms Julie A I, Yan Feng, Hampton Henry R, Davidson Sarah, Joshi Swapna, Saw Jesslyn, Sarowar Chowdhury H, Lim Xin Ying, Nunez Andrea C, Kakadia Purvi M, Bhuyan Golam Sarower, Zou Xiaoheng, Nguyen Mary, Ghodousi Elaheh S, Koch Forrest C, Vafaee Fatemeh, Thompson I Richard, Karimi Mohammad M, Pickford Russell, Raftery Mark J, Hough Sally, Buckland Griselda, Bailey Michelle, Ghodke Yuvaraj, Absar Noorul, Vaughan Lachlin, Pasalic Leonardo, Fong Chun Y, Kenealy Melita, Hiwase Devendra K, Stoddart Rohanna I, Mohammed Soma, Lee Linda, Passam Freda H, Larsen Stephen R, Spring Kevin J, Skarratt Kristen K, Rebeiro Patricia, Presgrave Peter, Stevenson William S, Ling Silvia, Tiley Campbell, Fuller Stephen J, Roncolato Fernando, Enjeti Anoop K, Hoenemann Dirk, Lemech Charlotte, Jolly Christopher J, Bohlander Stefan K, Curtis David J, Wong Jason W H, Unnikrishnan Ashwin, Hertzberg Mark, Olivier Jake, Polizzotto Mark N, Pimanda John E

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study

伊布替尼联合利妥昔单抗和mini-CHOP方案治疗老年新诊断弥漫性大B细胞淋巴瘤患者:一项2期ALLG研究

Verner, Emma; Johnston, Amanda; Pati, Nalini; Hawkes, Eliza A; Lee, Hui-Peng; Cochrane, Tara; Cheah, Chan Yoon; Filshie, Robin; Purtill, Duncan; Sia, Hanlon; Enjeti, Anoop K; Brown, Christina; Murphy, Nicholas; Curnow, Jennifer; Lee, Kenneth; Gandhi, Maher K; Walia, Mannu; Butcher, Belinda E; Trotman, Judith

Certainty in uncertainty: Determining the rate and reasons for reclassification of variants of uncertain significance in haematological malignancies

不确定性中的确定性:确定血液系统恶性肿瘤中意义未明变异的重新分类率和原因

Enjeti, Anoop K; Walker, Natasha; Fahey, Oliver; Johnston, Elizabeth; Legge-Wilkinson, Hannah; Ramsurrun, Nateika; Sillar, Jonathan; Lincz, Lisa F; Ziolkowski, Andrew; Mossman, David

Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia

急性髓系白血病中DNA甲基化与缺氧之间的相互作用

Humphries, Sam; Bond, Danielle R; Germon, Zacary P; Keely, Simon; Enjeti, Anoop K; Dun, Matthew D; Lee, Heather J

Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand

澳大利亚和新西兰成人免疫性血小板减少症管理共识指南

Choi, Philip Yi; Merriman, Eileen; Bennett, Ashwini; Enjeti, Anoop K; Tan, Chee Wee; Goncalves, Isaac; Hsu, Danny; Bird, Robert

COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement

血液病患者接种新冠病毒疫苗:澳大利亚和新西兰共识立场声明

McCaughan, Georgia; Di Ciaccio, Pietro; Ananda-Rajah, Michelle; Gilroy, Nicole; MacIntyre, Raina; Teh, Benjamin; Weinkove, Robert; Curnow, Jennifer; Szer, Jeff; Enjeti, Anoop K; Ross, David M; Mulligan, Stephen; Trotman, Judith; Dickinson, Michael; Quach, Hang; Choi, Phillip; Polizzotto, Mark N; Tam, Constantine S; Ho, P Joy; Ku, Matthew; Gregory, Gareth; Gangatharan, Shane; Hapgood, Greg; Cochrane, Tara; Cheah, Chan; Gibbs, Simon; Wei, Andrew; Johnston, Anna; Greenwood, Matthew; Prince, H Miles; Latimer, Maya; Berkahn, Leanne; Wight, Joel; Armytage, Tasman; Hamad, Nada

Unravelling the Epigenome of Myelodysplastic Syndrome: Diagnosis, Prognosis, and Response to Therapy

揭示骨髓增生异常综合征的表观基因组:诊断、预后和治疗反应

Bond, Danielle R; Lee, Heather J; Enjeti, Anoop K

Targeting Apoptotic Pathways in Acute Myeloid Leukaemia

靶向急性髓系白血病中的细胞凋亡通路

Sillar, Jonathan R; Enjeti, Anoop K

Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance

靶向突变型FLT3急性髓系白血病中的致癌信号通路:通往最小阻力之路

Staudt, Dilana; Murray, Heather C; McLachlan, Tabitha; Alvaro, Frank; Enjeti, Anoop K; Verrills, Nicole M; Dun, Matthew D